Even as the U.S. opioid crisis deepened and lawsuits flourished, Purdue Pharma continued to market Oxycontin to doctors. But no longer. The company said last week that it will stop promoting its opioid drugs to physicians.Original Article
Purdue Pharma finally stops marketing opioids to physicians—and cuts 200-plus representatives in the process
